Kambayashi T - Search Results

1

Neutrophils augment the release of TNFalpha from LPS-stimulated macrophages via hydrogen peroxide.

Sredni-Kenigsbuch D, Kambayashi T, Strassmann G. Sredni-Kenigsbuch D, et al. Among authors: kambayashi t. Immunol Lett. 2000 Feb 1;71(2):97-102. doi: 10.1016/s0165-2478(99)00157-1. Immunol Lett. 2000. PMID: 10714436

2

Cyclic nucleotide phosphodiesterase type IV participates in the regulation of IL-10 and in the subsequent inhibition of TNF-alpha and IL-6 release by endotoxin-stimulated macrophages.

Kambayashi T, Jacob CO, Zhou D, Mazurek N, Fong M, Strassmann G. Kambayashi T, et al. J Immunol. 1995 Nov 15;155(10):4909-16. J Immunol. 1995. PMID: 7594495

3

Potential involvement of IL-10 in suppressing tumor-associated macrophages. Colon-26-derived prostaglandin E2 inhibits TNF-alpha release via a mechanism involving IL-10.

Kambayashi T, Alexander HR, Fong M, Strassmann G. Kambayashi T, et al. J Immunol. 1995 Apr 1;154(7):3383-90. J Immunol. 1995. PMID: 7897221

4

IL-4 and IL-13 modulate IL-10 release in endotoxin-stimulated murine peritoneal mononuclear phagocytes.

Kambayashi T, Jacob CO, Strassmann G. Kambayashi T, et al. Cell Immunol. 1996 Jul 10;171(1):153-8. doi: 10.1006/cimm.1996.0186. Cell Immunol. 1996. PMID: 8660851

5

The immunomodulator AS-101 inhibits IL-10 release and augments TNF alpha and IL-1 alpha release by mouse and human mononuclear phagocytes.

Strassmann G, Kambayashi T, Jacob CO, Sredni D. Strassmann G, et al. Among authors: kambayashi t. Cell Immunol. 1997 Mar 15;176(2):180-5. doi: 10.1006/cimm.1997.1087. Cell Immunol. 1997. PMID: 9073392

6

Evidence for the involvement of interleukin 10 in the differential deactivation of murine peritoneal macrophages by prostaglandin E2.

Strassmann G, Patil-Koota V, Finkelman F, Fong M, Kambayashi T. Strassmann G, et al. Among authors: kambayashi t. J Exp Med. 1994 Dec 1;180(6):2365-70. doi: 10.1084/jem.180.6.2365. J Exp Med. 1994. PMID: 7525853 Free PMC article.

7

Vesnarinone is a selective inhibitor of macrophage TNF(alpha) release.

Kambayashi T, Mazurek N, Jacob CO, Wei N, Fong M, Strassmann G. Kambayashi T, et al. Int J Immunopharmacol. 1996 Jun-Jul;18(6-7):371-8. doi: 10.1016/s0192-0561(96)00037-9. Int J Immunopharmacol. 1996. PMID: 9024938

8

Vesnarinone inhibits immune-mediated but not Fas (CD95) agonist-mediated hepatic injury.

Lazarus DD, Kambayashi T, Yato-Kioka M, Baumann H, Jacob CO, Strassmann G. Lazarus DD, et al. Among authors: kambayashi t. Int J Immunopharmacol. 1997 Jan;19(1):49-58. doi: 10.1016/s0192-0561(96)00052-5. Int J Immunopharmacol. 1997. PMID: 9226479

9

The lack of an effect by insulin or insulin-like growth factor-1 in attenuating colon-2-mediated cancer cachexia.

Lazarus DD, Kambayashi T, Lowry Sf, Strassmann G. Lazarus DD, et al. Among authors: kambayashi t. Cancer Lett. 1996 May 15;103(1):71-7. doi: 10.1016/0304-3835(96)04197-3. Cancer Lett. 1996. PMID: 8616811 Free article.

10

Inhibition of experimental cancer cachexia by anti-cytokine and anti-cytokine-receptor therapy.

Strassmann G, Kambayashi T. Strassmann G, et al. Among authors: kambayashi t. Cytokines Mol Ther. 1995 Jun;1(2):107-13. Cytokines Mol Ther. 1995. PMID: 9384667 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

151 results

Search Page

Filters